Publications
- Efficacy and safety of 1C class antiarrhythmic agent (propafenone) for supraventricular arrhythmias in septic shock compared to amiodarone: Protocol of a prospective randomised double-blind study2019 | First Faculty of Medicine, Third Faculty of Medicine
- The impact of obesity on the outcome of severe SARS-CoV-2 ARDS in a high volume ECMO centre: ECMO and corticosteroids support the obesity paradox2022 | First Faculty of Medicine
- COVID-19 severe pneumonia: Prospective multicentre study on demands on intensive care capacities2021 | First Faculty of Medicine, Third Faculty of Medicine, Second Faculty of Medicine
- Propafenone for supraventricular arrhythmias in septic shock-Comparison to amiodarone and metoprolol. Reply2018 | First Faculty of Medicine
Loading network view...